Follow us...


Search News Archives

News Channels


Coronavirus (COVID-19)



View Channel

New Laboratory Products


View Channel

Lab News


View Channel

Research & Case Studies


View Channel

Microscopy | Image Analysis


View Channel

Separation Science


View Channel



View Channel

Events | Webinars


View Channel

Conferences | Events

Children’s Oncology Hospital Units utilise TAP’s Fill-It System for Immunotherapy Research To Determine Optimal Dose of Cancer Therapies and Create Stocks of Consistent, High Quality Product for Clinical Trials

publication date: Apr 23, 2014
author/source: TAP Biosystems

TAP biosystems

TAP Biosystems, (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture systems and consumables for life science applications, today announced its Fill-It™, automated cryovial filling system is being routinely used in clinical trials of novel cell-based cancer immunotherapies at children’s oncology units in three major US hospitals.

The system is being utilised in research labs to help determine the correct dosage of cells to treat children with life-threatening cancers, as well as to create stocks of consistent, high-quality product in cryovials for clinical trials.

Scientists at the hospitals are using Fill-It to produce batches of around 400 cryovials per run, with each 1ml vial containing between 40 and 100 million cell/ml of cell immunotherapy, depending on their requirements. These therapies consist of cancer cell lines donated from children suffering with life-threatening cancers.  From each batch of vials produced, clinicians select a number of vials to use as treatment for the children.  The remaining vials are frozen down and used at a later date.

The Fill-It automated system is ideally-suited to the demands of working with cell-based therapies as a rack of 24 product vials can be created every two minutes, maintaining optimum product quality and ensuring vial-to-vial consistency.  Each product is aseptically processed using GMP-certified, single-use tubing that has been specially-designed to ensure minimal cell damage during dispensing. 

Stephen Guy, Fill-It Product Manager at TAP commented: “This important clinical research application of our technology in major US hospitals demonstrates to scientists and clinicians in cell therapy units that a Fill-It system is an excellent technique of producing batches of vials for determining optimum cell therapy dosage, and for generating stocks of consistent, quality product for clinical trials.”

TAP Biosystems (now part of the Sartorius Stedim Biotech Group) is a leading global provider of automated cell culture and fermentation systems for life science research, development and production.

TAP's systems are in use worldwide at pharmaceutical, biotechnology and academic laboratories, supporting bioprocess development and GMP manufacture of biologics and cell therapies, discovery and stem cell research programmes.

more about TAP biosystems

more news from TAP Biosystems


If you have not logged into the website then please enter your details below.



Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd




Media Partners